GROUP ONE TRADING, L.P. - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 23 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$5,830,000
+1167.4%
331,989
+600.8%
0.01%
+500.0%
Q2 2021$460,000
-37.9%
47,371
-31.3%
0.00%0.0%
Q1 2021$741,000
-54.6%
68,950
-37.8%
0.00%
-66.7%
Q4 2020$1,632,000
+120.2%
110,924
+112.8%
0.00%
+50.0%
Q3 2020$741,000
+112.3%
52,133
+20.8%
0.00%0.0%
Q2 2020$349,00043,143
+43043.0%
0.00%
Q4 2018$0
-100.0%
100
-95.2%
0.00%
Q3 2018$12,0000.0%2,100
+5.0%
0.00%
Q2 2018$12,000
-14.3%
2,0000.0%0.00%
Q1 2018$14,0002,0000.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Opaleye Management Inc. 260,000$5,260,0002.44%
Avoro Capital Advisors LLC 160,697$3,234,0001.24%
Private Capital Advisors, Inc. 83,820$1,696,0000.62%
Monashee Investment Management LLC 25,000$506,0000.32%
SPHERA FUNDS MANAGEMENT LTD. 95,000$1,922,0000.20%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 226,064$4,573,0000.15%
Spark Investment Management LLC 36,700$745,0000.10%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,121$589,0000.04%
A.R.T. Advisors, LLC 15,480$313,0000.01%
Tower Research Capital LLC (TRC) 1,200$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders